Physician profile
Brian E Cook
NPI 1932381696
$10,452.19
in general payments reported to CMS, 2019-2025
35 companies · $2,039 in 2025
The $2,039 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,214 · 2022: $1,728 · 2023: $1,513 · 2024: $3,958 · 2025: $2,039.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,095 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,260 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,095.28 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,260.00 |
| Education | $154.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $2,138.01 | 2022-2025 | Opzelura, Opzelura |
| Abbvie INC. | $1,766.55 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,001.08 | 2022-2025 | Sotyktu |
| Leo Pharma INC. | $850.33 | 2021-2025 | Adbry |
| Dermavant Sciences, INC. | $556.62 | 2023-2024 | Vtama |
| Genzyme Corporation | $536.35 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $484.77 | 2021-2025 | |
| Janssen Biotech, INC. | $470.53 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Regeneron Healthcare Solutions, INC. | $415.52 | 2021-2025 | Dupixent, Libtayo |
| Pfizer INC. | $376.26 | 2021-2025 | |
| Arcutis Biotherapeutics, INC. | $350.45 | 2023-2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $238.37 | 2021-2024 | |
| Almirall LLC | $223.51 | 2022-2025 | Klisyri, Seysara |
| Ucb, INC. | $180.03 | 2022-2025 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $131.85 | 2021-2025 | Jublia, Cabtreo, Siliq |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $108.59 | 2024 | Daxxify |
| Sanofi-Aventis U.S. LLC | $89.95 | 2024 | |
| Amgen INC. | $69.80 | 2023-2025 | Otezla |
| Lilly USA, LLC | $59.19 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.27 | 2023 | Spevigo |
| Galderma Laboratories, L.P. | $43.27 | 2022-2025 | Nemluvio |
| Mayne Pharma Commercial LLC | $38.22 | 2022 | |
| Journey Medical Corporation | $33.98 | 2022-2025 | |
| Medimetriks Pharmaceuticals, INC. | $31.27 | 2025 | Clindacin Etz, Neo-Synalar |
| Kerecis Limited | $24.70 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Fresenius Kabi USA, LLC | $22.44 | 2023 | Idacio |
| Organon LLC | $21.79 | 2025 | Vtama |
| Merck Sharp & Dohme LLC | $21.68 | 2023 | Keytruda |
| Sandoz INC. | $21.45 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.67 | 2025 | Spravato |
| Novo Nordisk INC | $19.62 | 2021 | |
| Botanix Sb INC | $18.86 | 2025 | Sofdra |
| Allergan, INC. | $17.10 | 2021 | |
| Paratek Pharmaceuticals, INC. | $16.04 | 2021 | |
| Genentech USA, INC. | $10.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.